Friday 6 November 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.

Revenue: +9.86%
EPS: +17.3%
Free cash flow: +17.6%
Total debt: −28.6%

Quarter to September 2026, against a year earlier

677.66 6.95 +1.04%

Follow IDXX

Alert me

Market cap: $52.8B
P/E: 44.8×
Fwd P/E: 37.3×
Dividend yield: —
F-score: 8/9
Altman Z: 24.09
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IDEXX Laboratories, Inc. 10-Q filed May 5, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed May 5, 2026 · accepted 4:14 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 1, 2025: 13 added · 19 removed · 44 modified; 2 with only figures updated

IDEXX Laboratories, Inc. 10-Q filed May 5, 2026

What changed

Stockrow Weekly